Suppr超能文献

VIII 因子轻链足以加速 ADAMTS13 金属蛋白酶对血管性血友病因子的裂解。

Light chain of factor VIII is sufficient for accelerating cleavage of von Willebrand factor by ADAMTS13 metalloprotease.

机构信息

Department of Pathology and Laboratory Medicine, Children's Hospital of Philadelphia, Philadelphia, Pennsylvania 19104, USA.

出版信息

J Biol Chem. 2012 Sep 21;287(39):32459-66. doi: 10.1074/jbc.M112.390690. Epub 2012 Aug 1.

Abstract

We previously demonstrated that coagulation factor VIII (FVIII) accelerates proteolytic cleavage of von Willebrand factor (VWF) by A disintegrin and metalloprotease with thrombospondin type 1 repeats (ADAMTS13) under fluid shear stress. In this study, the structural elements of FVIII required for the rate-enhancing effect and the biological relevance of this cofactor activity are determined using a murine model. An isolated light chain of human FVIII (hFVIII-LC) increases proteolytic cleavage of VWF by ADAMTS13 under shear in a concentration-dependent manner. The maximal rate-enhancing effect of hFVIII-LC is ∼8-fold, which is comparable with human full-length FVIII and B-domain deleted FVIII (hFVIII-BDD). The heavy chain (hFVIII-HC) and the light chain lacking the acidic (a3) region (hFVIII-LCΔa3) have no effect in accelerating VWF proteolysis by ADAMTS13 under the same conditions. Although recombinant hFVIII-HC and hFVIII-LCΔa3 do not detectably bind immobilized VWF, recombinant hFVIII-LC binds VWF with high affinity (K(D), ∼15 nM). Moreover, ultra-large VWF multimers accumulate in the plasma of fVIII(-/-) mice after hydrodynamic challenge but not in those reconstituted with either hFVIII-BDD or hFVIII-LC. These results suggest that the light chain of FVIII, which is not biologically active for clot formation, is sufficient for accelerating proteolytic cleavage of VWF by ADAMTS13 under fluid shear stress and (patho) physiological conditions. Our findings provide novel insight into the molecular mechanism of how FVIII regulates VWF homeostasis.

摘要

我们之前的研究表明,在流体剪切应力下,凝血因子 VIII(FVIII)可加速血管性血友病因子(VWF)被解整合素金属蛋白酶与血小板反应蛋白 1 型重复序列(ADAMTS13)的蛋白水解切割。在这项研究中,我们使用鼠模型确定了 FVIII 中促进这一辅助因子活性的蛋白水解切割作用的结构元件以及该活性的生物学相关性。人 FVIII 的轻链(hFVIII-LC)可在剪切条件下浓度依赖性地增加 ADAMTS13 对 VWF 的蛋白水解切割。hFVIII-LC 的最大速率增强作用约为 8 倍,与全长 hFVIII 和 B 结构域缺失的 FVIII(hFVIII-BDD)相当。在相同条件下,重链(hFVIII-HC)和缺乏酸性(a3)区的轻链(hFVIII-LCΔa3)对 ADAMTS13 促进 VWF 蛋白水解没有作用。尽管重组 hFVIII-HC 和 hFVIII-LCΔa3 不能检测到与固定化 VWF 结合,但重组 hFVIII-LC 可与 VWF 高亲和力结合(K(D),约 15 nM)。此外,在流体剪切应力和(病理)生理条件下,超大型 VWF 多聚体在水力冲击后积聚在 fVIII(-/-)小鼠的血浆中,但在 hFVIII-BDD 或 hFVIII-LC 重建的血浆中没有积聚。这些结果表明,FVIII 的轻链对于血栓形成没有生物学活性,但足以在流体剪切应力下加速 ADAMTS13 对 VWF 的蛋白水解切割。我们的研究结果为 FVIII 如何调节 VWF 内稳态的分子机制提供了新的见解。

相似文献

5

引用本文的文献

2
8
Probing ADAMTS13 substrate specificity using phage display.利用噬菌体展示技术探究ADAMTS13的底物特异性
PLoS One. 2015 Apr 7;10(4):e0122931. doi: 10.1371/journal.pone.0122931. eCollection 2015.
9
Structure-function and regulation of ADAMTS-13 protease.ADAMTS-13 蛋白酶的结构-功能与调控。
J Thromb Haemost. 2013 Jun;11 Suppl 1(0 1):11-23. doi: 10.1111/jth.12221.

本文引用的文献

9
Pathogenesis of thrombotic microangiopathies.血栓性微血管病的发病机制。
Annu Rev Pathol. 2008;3:249-77. doi: 10.1146/annurev.pathmechdis.3.121806.154311.

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验